All PlansAdministrativeMedium impact
MolDX: Biomarker Testing in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis
Medicare/CMS - LCD·Local Coverage Determination
We identified it
Jun 25, 2026
Summary
Failed to analyze policy change